We present a standardized Pseudomonas aeruginosa (PA) infected burn-wound model in mice for evaluating new antimicrobials and therapy strategies for PA infections and demonstrate the effect of the antibiotic imipenem in this model. Methods: A 6%-8% total body surface area, full-thickness, scaldburn wound was induced in anesthetized mice. Two study groups (PA-infected burn) were compared with 1 treatment group (systemic imipenem) and 3 control groups (noninfected burn, infected nonburned, and burn with distant infection). Seven-day mortality, quantitative culture from eschars and from spleens, weight loss, and time to healing were compared. Results: The 25%-100% mortality rate in the nontreated PAinfected burn group was directly related to the infecting inoculum. Imipenem treatment reduced the mortality rate to 0 -17%. No control animal died. Systemic bacterial dissemination at 48 hours was significantly higher in the study group. Morbidity paralleled survival results. Wound healing was quicker in the imipenem-treated group and control groups compared with the infected nontreated group. Conclusions: The mice model is a useful tool for evaluating new antibacterial agents and strategies for treating PA-infected burn injuries. Imipenem was found to be efficacious in the treatment of severe PA sepsis.
E
ffective fluid resuscitation, intensive-care monitoring in the acute period, and acute eschar excision following with an immediate closure of the wound have increased the number of surviving patients with burns that involve major thermal injuries. [1] [2] [3] [4] [5] [6] Infections, however, continue to be the major concern, reportedly causing over 50% of burn deaths. 4, 6 The presence of coagulated proteins and other microbial nutrients in the wound and the avascularity of the eschar which prevents delivery of immunologically active cells, humoral factors, and antibiotics to it provide an optimal environment for bacterial growth and the development of infection. [1] [2] [3] [4] [5] [6] Moreover, prolonged hospitalization and invasive diagnostic and therapeutic procedures further contribute to the infectious process. [1] [2] [3] [4] [5] [6] Pseudomonas aeruginosa (PA) is an opportunistic gramnegative pathogen involved in serious infections in immunocompromised hosts, characteristic of patients with severe burn wounds. [7] [8] [9] The ability of PA to survive under different environmental conditions, combined with its inherent resistance to several antibiotics, allows it to colonize and proliferate within the burned tissues. This localized proliferation may lead to systemic sepsis, which is often associated with a high degree of morbidity and mortality. [7] [8] [9] [10] [11] Numerous experimental burn wound animal models, [12] [13] [14] [15] [16] [17] [18] and specifically PA-infected burn models, 7,8,11,19 -25 have been developed in an effort to study the pathophysiology of burn wounds and the pathogenesis of PA burn wound infection. The main problem inherent in these animal models is their clinical relevance; when evaluating antimicrobial therapy, mortality and morbidity are related to the burn per se rather than to the infection, which may confound results even when an effective antimicrobial is used.
Imipenem is a broad-spectrum antibiotic agent important for treating polymicrobial infections, particularly those caused by resistant organisms. 26 Imipenem was studied and found to be an effective treatment against P. aeruginosa infections 26 ; however, it was not evaluated in a burn-wound sepsis model.
We established a standardized and reproducible murine PA-infected burn-wound model. This model was designed to resemble as closely as possible human burn-wound sepsis for better understanding of the pathogenesis of PA burn-wound infection in nonexcised burn wounds. Our objective was to provide a valid means for testing treatment modalities and evaluate the efficacy of imipenem in this model.
MATERIALS AND METHODS

Animals
Adult female CBL57 inbred mice (18 -20 g; Harlan Laboratories, Rehovot, Israel) were housed 6 per individually ventilated cages (IVC; Techniplast, Italy) in a central animal research facility. The facility maintains an environment of controlled temperature and relative humidity, with a 12-hour light/dark cycle. The mice were supplied with sterile bedding, standard chow, and water and were acclimatized for 5 days before each experiment. They were kept in a specific pathogen-free environment at all times. All procedures, care, and handling of the animals were reviewed and approved by the Institutional Animal Care and Use Committee at the Tel-Aviv Sourasky Medical Center.
The animals were randomly assigned to 2 study groups (PA-infected burn: PAO1, n ϭ 12 and PA409, n ϭ 12 which were compared with 1 treatment group (systemic imipenem, n ϭ 12) and 3 control groups (noninfected burn n ϭ 12, infected nonburned n ϭ 12, and burn with distant infection n ϭ 12).
Burn-Wound Model
The mice were individually labeled and weighed before each experiment. They were anesthetized by an intraperitoneal injection of 1.2 mg sodium pentobarbital (Nembutal, Abbott Laboratories, IL), and fur was removed thoroughly from the right posterior flank area by a shaver and depilatory cream. For burn induction, the anesthetized mice were placed onto a heat-resistant polypropylene template with a 1 ϫ 2 cm opening. The shaved right side was directly exposed to a 90°C waterbath. The area of the burn was calculated by the Mee's formula 12 : A ϭ kW 2/3 (A ϭ surface area in cm 2 , W ϭ body weight in grams, k ϭ animal coefficient). Burn area was approximately 6%-8% of the murine body surface area. Various exposure times in the 90°C waterbath (ie, 3, 6, 8, and 10 seconds) were tested on groups of 6 mice each to induce a nonlethal full-thickness burn wound. Immediately afterward, the burned area was immersed in a 23°C waterbath, and the mice were resuscitated with 0.5 mL of saline administered intraperitoneally. Acetaminophen (0.25 mg/mL) in the drinking water was used as a postburn analgesic.
Bacterial Infection
Infection was induced immediately after burn formation and fluid resuscitation by a subeschar injection of 0.1 mL of a logarithmic culture of PA. Two PA strains were studied in our model: an ATCC strain PA01 and a clinical strain PA409. Both strains were imipenem susceptible, tested by a standard susceptibility testing recommended by the Clinical Laboratory Standards (CLSI). The infecting bacterial inoculum from each strain was prepared in brain heart infusion broth (BHI; Becton-Dickinson) with agitation (180 RPM) at 37°C for 5-6 hours. The cells were harvested (optical density of 0.8 at 620 nm), centrifuged and resuspended in a sterile BHI. The number of infecting bacteria was verified by plating serial dilutions of the injected inocula onto BHI agar plates.
The lethal doses of PAO1 and PA409 in the infected burn model were determined for each bacterium separately by subeschar injections of increasing amounts of inocula (ranging from 1 ϫ 10 5 to 5 ϫ 10 6 colony forming units ͓CFU͔ per mouse) from each bacterium into groups of 12 mice and by the monitoring of mice survival during the ensuing 14 days. Imipenem efficacy was studied by administrating imipenem to an infected-burn-wound group. Imipenem (0.5 mg) was given intraperitoneally 4 hours after infection and twice daily for 4 days.
Three control groups were designed for the model: (1) a burn group with no infection; (2) a burn group with contralateral (left flank) infection, ie, distant from the burn area; (3) a bacterial infected nonburned group, injecting the bacteria subcutis into the shaved right flank area.
Morbidity, Mortality, Wound Healing, and Histopathology Follow-up
Morbidity and mortality were monitored daily in the control and experimental groups (n ϭ 12 animals per subgroup), for a period of 14 days from induction of infections. Morbidity was determined by monitoring the individual mouse's daily weight changes. Dead animals were excluded from the morbidity evaluation. Wound healing was determined by the time needed for complete reepithelialization of a burn wound. The burn wounds were photographed and documented throughout a 4-week period. Histopathology of the wounds was carried out on subeschar biopsies removed from burned areas on days 2 and 14. Biopsy specimens (4 mm in diameter) were fixed in 10% formaldehyde, processed for standard hematoxylin and eosin staining, and evaluated by light microscopy ϫ40.
Microbiologic Analysis
Surviving mice were killed (n ϭ 4 from each group at each time point at various time intervals from infection (6 hours, 1 and 2 days), and bacterial counts were taken from the burn areas (as a measure of local proliferation) and from the spleen (as a measure of systemic dissemination ͓bacteremia͔). Samples from each animal's burn area and spleen were taken aseptically, weighed, homogenized, and resuspended in a sterile saline solution. Bacterial counts of PA per gram of tissue (eschar or spleen) were determined by serial dilutions of the sample and by colony counting on the BHI agar plates after an overnight incubation. The average concentrations of PA in the burn and in the spleen were calculated from an average of bacterial counts obtained from 4 mice that were killed at each time point.
Statistical Analysis
Statistics were run in Stata version 7 (Stata Corp., College Station, TX). The differences in the results of the selected parameters between the PA-infected burn group and the control groups were analyzed. Dichotomous outcomes (mortality) were evaluated by Fisher exact test and continuous variables (average daily weight change) by Student t test.
Comparison of time to wound healing was performed using the log-rank test, although usually applied to larger samplesized groups. All tests were 2-sided, and a P value Ͻ0.05 was considered statistically significant.
RESULTS
Burn Induction
To establish an infected-burn-wound model without the necessity of eschar excision, we induced 6%-8% full-thickness-sized burns in which mortality was restricted only to the infected burn. Initially, the appropriate time of thermal exposure was determined. Repetitive early histopathology of specimens removed from the burn area at various exposure times to hot water (90°C) demonstrated a correlation between the time of exposure and the depth of the burn (Fig. 1) . Skin exposure of 3 seconds caused a burn wound involving the epidermis and the upper part of the dermis (partial-thickness, second-degree burn), while 6 seconds of exposure resulted in a burn wound involving all the epidermis and dermis of the skin (full-thickness, third-degree burn). Longer exposure time to hot water (8 and 10 seconds) resulted in full-thickness burns with subcutaneous fat and muscle involvement (Fig. 1) . Thus, the exposure time chosen for this model was 6 seconds, sufficient for inducing a full-thickness burn and with minimal subcutaneous fat involvement. There was no mortality among the 24 mice in which burn was induced under these conditions.
Animal Mortality
To determine the appropriate PA inocula for infecting the burn wounds in this model, the survival of burned mice infected with 2 different Pseudomonas strains was measured. per burn of Pseudomonas strain PA01, survival rates within 14 days were 75%, 58%, 42%, and 17%, respectively ( Fig.  2A) , while for the clinical strain PA409, they were 17%, 8%, 0%, and 0%, respectively (Fig. 2B) . Fatalities almost invariably (Ͼ90%) occurred within the first 4 days, mostly between 48 and 56 hours. The infecting bacterial inocula chosen for further study in this model were 5 ϫ 10 6 CFU per burn of PA01 and 1 ϫ 10 5 CFU per burn of PA409, inducing a mortality rate of approximately 80%-90% at 7 days and no mortality thereafter. Imipenem treatment increased the sur- vival of mice infected with each strain of Pseudomonas from 17% to 100% (Fig. 3 , P Ͻ 0.001). Survival in the infected nonburned group and in the contralateral flank-infected burn group was 100% for both PA strains when using the same infecting inocula, as demonstrated in Figure 3 .
Bacterial Burn Infection and Sepsis
We examined the presence of both local bacterial proliferation (burn area) and systemic dissemination of the bacteria (Fig. 4) . Bacterial counts performed in the burn area during the first 24 hours from infection demonstrated an exponential increase (approximately 3 ϫ log) in the bacterial load in the infected burn as well as in the imipenem-treated burned groups: the bacterial load increased from 3 ϫ 10 5 CFU/g to 1.5 ϫ 10 8 CFU/g eschar and to 7.1 ϫ 10 7 CFU/g eschar, respectively. After the first day, the bacterial load in the burn area remained stable and even decreased slightly (Fig. 4A) . The initial injected bacterial load was recovered from the burn area in the infected nonburn group and was seen to have doubled during the first 6 hours from infection, after which it completely disappeared.
Systemic bacterial dissemination was evident in the nontreated infected burn group (Fig. 4B) . Infecting bacteria began to appear in the spleen 6 hours postinfection, reaching 4.3 ϫ 10 5 CFU/g spleen after 1 day from infection and peaking at 3 ϫ 10 6 CFU/g spleen 2 days after infection. In the imipenem-treated PA-409-infected burn group, bacteria appeared in the spleen at a similar time but in a much lower load (2.3 ϫ 10 3 CFU/g at 1 day), reaching a concentration of 3.7 ϫ 10 3 CFU/g spleen at 2 days, a 3-log lower load compared with the untreated group (P ϭ 0.03). The infected nonburned group showed no bacterial growth in the spleen (Fig. 4B ).
Mice Weight Loss and Wound Healing
Daily murine weight changes after bacterial challenge with PA01 revealed a rapid weight loss in all infected groups (days 2-3), followed by a steady weight gain in the surviving mice, until the mice reached a constant weight level 2 weeks postinfection (Fig. 5) . Maximal weight loss occurred in all groups on the second day from infection, with a maximum weight loss of 17% in the infected burned group. The relative weight loss was similar and of lesser magnitude in the 
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imipenem-treated group and in the infected nonburned group (9.3%, and 10.8%, respectively, P Ͻ 0.05). After 14 days, the infected nonburned mice regained their initial weight, whereas the infected burn group had a residual weight loss of 6%, as seen in Figure 5 . A rapid weight loss pattern was observed in mice infected with PA409 strain as well (data not shown). With this highly virulent strain (as demonstrated in Fig. 2 ), at inoculum of 3 ϫ 10 5 CFU per mice for example, most of the mice (11 out of 12) died during the first 30 hours from infection, and therefore it was inapplicable to calculate the average weight loss in surviving mice.
Wound healing with complete reepithelialization of the burn wound in surviving mice was achieved more rapidly in the imipenem-treated infected burned mice (complete wound healing at days 13, 16, 17, 17, 14, 15, 14) compared with the nontreated infected burned mice (complete wound healing at days 20, 27, 24, 23, 21). The average wound healing time in mice treated with imipenem was 15 days compared with 23 days in the PA-infected group (P ϭ 0.001). Burn histopathology performed 2 days after the infected burn had been induced in the nontreated group demonstrated skin with full-thickness dermal coagulation, with focal fat necrosis and inflammatory infiltrate in the subcutis. Fourteen days after the burn had been inflicted, the skin exhibited full-thickness necrosis, ulceration, and abscesses in the dermal, subcutaneous, and intramuscular layers. In contrast, burn histopathology of samples removed 14 days postinfection from both the noninfected burned mice and from the imipenem-treated infected burn groups showed dermal and subcutaneous fibrosis, granulation tissue with inflammation, and regenerative changes in the epidermis layer.
DISCUSSION
The aim of our current study was to establish a standardized severe murine PA-infected burn wound model for evaluating the pathogenesis of infection in burn wounds, as well as for measuring the efficacy of imipenem as a treatment of burn wound sepsis without the need of eschar excision. For simulating the setting of an infection, the interaction between PA and the host is a complex one and strongly dependent on the local wound environment of the host, on the host's humoral and cellular response to the injury and infection, and on the virulence of the PA. [7] [8] [9] [10] [11] A valid animal burn wound model must resemble this interaction as close as possible to human infected burn wound to be of any potential clinical value. We applied our model to the study of 2 strains of PA, one a laboratory strain (PA01) and the other a clinical strain (PA409), to observe the virulence variation in a PA-infected burn wound.
Mortality in burn wound models can be attributed to a number of etiologies: the burn trauma alone with hemodynamic and body temperature instability, the injected bacterial load alone, the secondary infection due to the immunocompromised state of the burned mice, and bacterial translocation from the gastrointestinal tract. [1] [2] [3] [4] [5] [6] To test the theory of burn wound infection leading to sepsis and mortality in our model, we studied a PA-infected burn group and compared it to an imipenem-treated group and several control groups. We also took histopathology samplings and quantified the bacteria both locally (from the burn itself) and systemically (from the spleen).
Having determined that burn wound depth was directly influenced by skin exposure time to water at a temperature of 90°C (Fig. 1) , the conditions for induction of the desired, nonlethal, full-thickness burn of about 6%-8% of the body surface area were exposure for 6 seconds to water at 90°C. There was a dose-dependent effect for given burn conditions, ie, the infecting PA inoculum was proportional to the mortality rate, and so the infecting bacterial inocula we chose for further studies were those that led to high rates of mortality (5-50 ϫ LD50); 5 ϫ 10 6 CFU/burn for the laboratory strain PA01 and 2 ϫ 10 6 CFU/burn for the more virulent clinical strain PA409. By using relatively high inocula of infecting bacteria, we could evaluate the effectiveness of imipenem and determine both clinical and statistical significance of the outcome compared with nontreated and control groups.
The low survival in PA-infected burn mice compared with 100% survival in all the control groups included in this model indicated that mortality was due to the bacteria in the burn area. The infected burn group that had been treated with 6 CFU PA01 were measured every day for 14 days, and the relative weights were calculated (relative to the average initial weights of each group). Relative weights over time revealed a rapid weight loss, followed by a steady weight gain, reaching constant weight at 2 weeks postinfection. Mice treated with imipenem (IMP) following infection showed less weight loss than the untreated PA01-infected burn group.
the antibiotic imipenem showed a significant increase in survival rate, thus reflecting the potential of this antibiotic in treating burn wound sepsis and the model for evaluating the effectiveness of other antibacterial agents. Local and systemic infection as determined by serial bacterial counts taken from the burn area and spleen, respectively, displayed similar bacterial counts in the burns of both nontreated and imipenem-treated PA-infected burned groups (Fig. 4A ). In contrast, the systemic bacteremia that was observed in the animals that underwent both burn and infection was significantly higher in the nontreated infected burn group compared with the imipenem-treated group (Fig. 4B) . It is suspected that PA has an intrinsic ability to expeditiously multiply in nonviable tissue and to actively invade viable underlying tissues as early as 6 hours from exposure. 24 This could explain the significant difference in bacterial counts between the different groups in our study.
Daily weight change follow-up represented the morbidity of the surviving animals in our model. All the infected animals lost weight during the first 2 days after injury despite fluid resuscitation (Fig. 5 ), presumably as a result of the raised catabolism of body tissues. 5 The PA-infected burn group had a significantly steeper weight loss within the first 48 hours after infection and a slower, incomplete weight recovery after 2 weeks compared with the imipenem-treated group and the infected nonburn group (Fig. 5) . Daily weight changes were found to parallel mortality rates in our model and can apparently serve as another important and simple follow-up tool in future models.
The microscopic and macroscopic follow-up findings of burn wound healing that we performed in the various groups of this model were in accordance with the differences in their mortality and morbidity rates.
In conclusion, the efficacy of imipenem in treating PA-infected burn wound sepsis was shown in the studied model. This model enables examination of multiple follow-up parameters, including mortality, morbidity, wound healing, histopathology, and bacterial counts (local and systemic). It is relatively simple to perform and requires commonly available laboratory equipment. Moreover, different PA strains can be calibrated for further studies on PA pathophysiology and resistance.
